Shortly after he became CEO of Bayer AG in 2023, CEO Bill Anderson began waging war against bureaucracy to make the life ...

Roche's drug portfolio shows promise, but mixed indicators reveal uncertainties. Check out the risks, opportunities, and ...

CAMBRIDGE, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining ...

The addition of brentuximab vedotin to lenalidomide and rituximab extended survival among heavily pretreated patients with ...

Adding obinutuzumab to standard therapy for active lupus nephritis led to significantly higher rates of complete renal ...

Former Stanford Research Coordinator Convicted for Unlawfully Accessing and Altering Breast Cancer Study Database Hours After ...

The federal crackdown on DEI initiatives is unlikely to deter companies from designing more representative trials, as it’s ...

PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neuromodulation company pioneering a breakthrough non-invasive treatment approach for amyotrophic lateral sclerosis (ALS), is pleased to ...

Naheed Mangi, a former Stanford coordinator, was found guilty of tampering with a breast cancer study database.

On this episode of Fortune’s Leadership Next podcast, co-hosts Diane Brady, executive editorial director of the Fortune CEO ...

Marya Lieberman is a chemistry professor whose NIH-funded project is focused on developing a tool to detect poor-quality ...